The First Affiliated Hospital of Xiamen University
🇨🇳China
68Ga-MY6349 PET/CT in Solid Tumors
Recruiting
- Conditions
- PET/CTTrop2Solid Tumor
- First Posted Date
- 2025-07-01
- Last Posted Date
- 2025-07-01
- Target Recruit Count
- 300
- Registration Number
- NCT07046702
- Locations
- 🇨🇳
The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
🇨🇳The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
PET/CT for Trop2 ADC Response Evaluation Cancers
Recruiting
- Conditions
- Breast CancerTrop2PET/CT
- First Posted Date
- 2025-07-01
- Last Posted Date
- 2025-07-01
- Target Recruit Count
- 50
- Registration Number
- NCT07046689
- Locations
- 🇨🇳
The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
T-cell Developmental Status in Patients With Malignant Hematological Tumors
Recruiting
- Conditions
- Hematologic Malignancy
- First Posted Date
- 2025-06-25
- Last Posted Date
- 2025-07-01
- Target Recruit Count
- 75
- Registration Number
- NCT07035938
- Locations
- 🇨🇳
Zhijuan Lin, Xiamen, Fujian, China
Effective Dose and Safety of Esketamine During Ultrasound-guided Hepatic Tumor Thermal Ablation
Phase 1
Active, not recruiting
- Conditions
- Hepatic NeoplasmHepatic Cancer
- Interventions
- Drug: Intravenous esketamine using Dixon's up-and-down sequential methodDrug: Intravenous the dose of esketamine ED95Drug: Intravenous fentanyl 1 μg∙kg-1
- First Posted Date
- 2025-06-24
- Last Posted Date
- 2025-07-02
- Target Recruit Count
- 79
- Registration Number
- NCT07034950
- Locations
- 🇨🇳
Department of Anesthesiology, The First Affiliated Hospital of Xiamen University, 55 Zhenhai Road, Xiamen, China, Xiamen, Fujian, China
Study on the Effective Dose and Safety of Esketamine in Hysteroscopic Surgery Under Monitored Anesthesia Care
Phase 1
Active, not recruiting
- Conditions
- Intrauterine PolypIntrauterine Synechiae
- Interventions
- Drug: Determine the ED50 and ED95 of esketamineDrug: Intravenous the dose of esketamine ED95Drug: Intravenous remifentanil 1μg∙kg-1
- First Posted Date
- 2025-06-24
- Last Posted Date
- 2025-06-27
- Target Recruit Count
- 95
- Registration Number
- NCT07034963
- Locations
- 🇨🇳
Department of Anesthesiology, The First Affiliated Hospital of Xiamen University, 55 Zhenhai Road, Xiamen, China, Xiamen, Fujian, China
A Single-arm, Multicenter, Prospective Clinical Study of Adebrelimab Combined With Apatinib Neoadjuvant Therapy for Resectable Non-small Cell Lung Cancer
Phase 2
Not yet recruiting
- Conditions
- Non-Small Cell Lung CancerAdebrelimabApatinib
- Interventions
- First Posted Date
- 2025-06-22
- Last Posted Date
- 2025-06-22
- Target Recruit Count
- 43
- Registration Number
- NCT07031154
- Locations
- 🇨🇳
First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
Tislelizumab Combined With Chemotherapy for the Perioperative Treatment of Esophageal Squamous Carcinoma
Phase 2
Not yet recruiting
- Conditions
- Esophagus Cancer
- Interventions
- First Posted Date
- 2025-06-13
- Last Posted Date
- 2025-06-13
- Target Recruit Count
- 26
- Registration Number
- NCT07019181
Ultrasound Assessment of Fetal Growth Parameters
- Conditions
- Fetal Clavicle LengthFetal Scapular WidthFetal Sternal LengthFetal Scapular LengthPerinatal Outcomes of the Mother and Fetus
- First Posted Date
- 2025-06-12
- Last Posted Date
- 2025-06-12
- Target Recruit Count
- 1000
- Registration Number
- NCT07018362
- Locations
- 🇨🇳
EPIQ 7 (Philips Healthcare, Bothell, WA) 和 Voluson E10 (GE Healthcare, Milwaukee, WI), Xiamen, Fujian, China
Trilaciclib in Patients Receiving Sacituzumab Tirumotecan for EGFR-mutated, Advanced Non-Small Cell Lung Cancer (NSCLC)
Phase 2
Not yet recruiting
- Conditions
- NSCLC (Advanced Non-small Cell Lung Cancer)EGFRMyelosuppression
- Interventions
- Drug: Trilaciclib and Sacituzumab Tirumotecan
- First Posted Date
- 2025-05-28
- Last Posted Date
- 2025-05-28
- Target Recruit Count
- 49
- Registration Number
- NCT06992739
Exploring the Clinical Application Value of CAIX-Targeted PET Imaging in Renal Cancer Patients
Recruiting
- Conditions
- TumorCarbonic Anhydrase IX
- First Posted Date
- 2025-05-02
- Last Posted Date
- 2025-05-29
- Target Recruit Count
- 113
- Registration Number
- NCT06956144
- Locations
- 🇨🇳
The First Affiliated Hospital of Xiamen University, Xiamen, Fujian 361000, Xiamen, China